Obagi operates in Healthcare, Cosmetics, Dermatology, functioning as Manufacturer and Distributor and Retailer, based in United States, founded in 1988.
Obagi is active in Healthcare, Cosmetics, Dermatology, with 3 identified product associations including Clenziderm Pore Therapy, Obagi C-Therapy Night Cream, and 3 ingredient links such as Hydrated Silica, Disodium Phosphate, operating from United States.
Obagi is linked to 3 ingredients: Hydrated Silica, Disodium Phosphate, Ethylparaben. INCI names include silica, Ethylparaben. CAS references: 7558-79-4, 120-47-8.
Obagi has 3 product records: Clenziderm Pore Therapy, Obagi C-Therapy Night Cream, Obagi C-Therapy Clarifying Serum, under brands: Sciences de la Peau CRESCITA Inc. /CRESCITA skin sciences Inc, Obagi Medical Products, a division of Valeant Pharmaceuticals North America LLC., within the Healthcare ecosystem.
Obagi has 71 people records, including Supply Chain Manager, Supply Chain Project Specialist, across Manager, Entry, manager levels.
This profile combines organization, product, ingredient, and narrative signals into a higher-fidelity company record.
INCI: silica
CAS: 7558-79-4
CAS: 120-47-8
Brand: Sciences de la Peau CRESCITA Inc. /CRESCITA skin sciences Inc · Industry: Healthcare
Brand: Obagi Medical Products, a division of Valeant Pharmaceuticals North America LLC. · Industry: Healthcare
Brand: Obagi Medical Products, a division of Valeant Pharmaceuticals North America LLC. · Industry: Healthcare
Obagi has 71 people records, including Supply Chain Manager, Supply Chain Project Specialist, across Manager, Entry, manager levels.
Obagi is related to companies such as ARFAMEX Dermatology, Optaderm Pharma Incorporated, DermaMedica d.o.o., identified through shared industry signals, ingredient overlap, and product ecosystem alignment.
Data-backed questions about Obagi in Healthcare, Cosmetics, Dermatology, United States.
© Copyright 2026 Dietary Business Intelligence LLC. All Rights Reserved.
